These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 11684140

  • 1. Trait anxiety and the effect of a single high dose of diazepam in unipolar depression.
    Bruijn JA, Moleman P, van den Broek WW, Mulder PG.
    J Psychiatr Res; 2001; 35(6):331-7. PubMed ID: 11684140
    [Abstract] [Full Text] [Related]

  • 2. Depressed in-patients respond differently to imipramine and mirtazapine.
    Bruijn JA, Moleman P, Mulder PG, van den Broek WW.
    Pharmacopsychiatry; 1999 May; 32(3):87-92. PubMed ID: 10463374
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine.
    Cankurtaran ES, Ozalp E, Soygur H, Akbiyik DI, Turhan L, Alkis N.
    Support Care Cancer; 2008 Nov; 16(11):1291-8. PubMed ID: 18299900
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A double-blind, fixed blood-level study comparing mirtazapine with imipramine in depressed in-patients.
    Bruijn JA, Moleman P, Mulder PG, van den Broek WW, van Hulst AM, van der Mast RC, van de Wetering BJ.
    Psychopharmacology (Berl); 1996 Oct; 127(3):231-7. PubMed ID: 8912401
    [Abstract] [Full Text] [Related]

  • 7. The pharmacologic rationale for the clinical use of antidepressants.
    Pinder RM.
    J Clin Psychiatry; 1997 Nov; 58(11):501-8. PubMed ID: 9413422
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Open trial study of a combined antidepressant (amitryptiline, perphenazine, diazepam) versus fluoxetine or imipramine in ambulatory depressed patients.
    Diaz A, Fouilloux C, Ortiz S.
    Proc West Pharmacol Soc; 2002 Nov; 45():154-5. PubMed ID: 12434564
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A risk-benefit assessment of mirtazapine in the treatment of depression.
    Kasper S, Praschak-Rieder N, Tauscher J, Wolf R.
    Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961
    [Abstract] [Full Text] [Related]

  • 13. Mirtazapine compared with paroxetine in major depression.
    Benkert O, Szegedi A, Kohnen R.
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
    Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S, Mirtazapine-Venlafaxine Study Group.
    J Clin Psychopharmacol; 2001 Aug; 21(4):425-31. PubMed ID: 11476127
    [Abstract] [Full Text] [Related]

  • 16. Detection and treatment of depressive and anxiety disorders among cancer patients: feasibility and preliminary findings from a liaison service in an oncology division.
    Pasquini M, Biondi M, Costantini A, Cairoli F, Ferrarese G, Picardi A, Sternberg C.
    Depress Anxiety; 2006 Aug; 23(7):441-8. PubMed ID: 16841345
    [Abstract] [Full Text] [Related]

  • 17. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K, DeMartinis N, García-España F, Greenblatt DJ, Mandos LA, Rynn M.
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.